4//SEC Filing
Silver Gabrielle Alison 4
Accession 0001385508-21-000085
CIK 0001385508other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:05 PM ET
Size
7.6 KB
Accession
0001385508-21-000085
Insider Transaction Report
Form 4
Silver Gabrielle Alison
Director
Transactions
- Award
Common Stock
2021-06-15+2,000→ 18,843 total - Award
Stock Option (right to buy)
2021-06-15+2,500→ 2,500 totalExercise: $13.30From: 2022-06-15Exp: 2031-06-14→ Common Stock (2,500 underlying)
Footnotes (2)
- [F1]2,000 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule: 100% vest on the one year anniversary date or the date of the 2022 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through such date.
- [F2]On June 15, 2021, the reporting person was granted 2,500 non-qualified stock options. 100% of the options vest on the one year anniversary of the grant date or the date of the 2022 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through such date.
Documents
Issuer
OPIANT PHARMACEUTICALS, INC.
CIK 0001385508
Entity typeother
Related Parties
1- filerCIK 0001685532
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:05 PM ET
- Size
- 7.6 KB